Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients who have had a first episode of unprovoked venous thromboembolism have a high risk of recurrence after anticoagulants are discontinued. Aspirin may be effective in preventing a recurrence of venous thromboembolism. METHODS: We randomly assigned 822 patients who had completed initial anticoagulant therapy after a first episode of unprovoked venous thromboembolism to receive aspirin, at a dose of 100 mg daily, or placebo for up to 4 years. The primary outcome was a recurrence of venous thromboembolism. RESULTS: During a median follow-up period of 37.2 months, venous thromboembolism recurred in 73 of 411 patients assigned to placebo and in 57 of 411 assigned to aspirin (a rate of 6.5% per year vs. 4.8% per year; hazard ratio with aspirin, 0.74; 95% confidence interval [CI], 0.52 to 1.05; P=0.09). Aspirin reduced the rate of the two prespecified secondary composite outcomes: the rate of venous thromboembolism, myocardial infarction, stroke, or cardiovascular death was reduced by 34% (a rate of 8.0% per year with placebo vs. 5.2% per year with aspirin; hazard ratio with aspirin, 0.66; 95% CI, 0.48 to 0.92; P=0.01), and the rate of venous thromboembolism, myocardial infarction, stroke, major bleeding, or death from any cause was reduced by 33% (hazard ratio, 0.67; 95% CI, 0.49 to 0.91; P=0.01). There was no significant between-group difference in the rates of major or clinically relevant nonmajor bleeding episodes (rate of 0.6% per year with placebo vs. 1.1% per year with aspirin, P=0.22) or serious adverse events. CONCLUSIONS: In this study, aspirin, as compared with placebo, did not significantly reduce the rate of recurrence of venous thromboembolism but resulted in a significant reduction in the rate of major vascular events, with improved net clinical benefit. These results substantiate earlier evidence of a therapeutic benefit of aspirin when it is given to patients after initial anticoagulant therapy for a first episode of unprovoked venous thromboembolism. (Funded by National Health and Medical Research Council [Australia] and others; Australian New Zealand Clinical Trials Registry number, ACTRN12605000004662.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consequently, several studies have investigated the role of aspirin for the secondary prevention of VTE. 309,314,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [315]
In the citing paper
“The WARFASA 309 and ASPIRE 318 trials compared aspirin, 100 mg daily, with placebo for secondary prevention of recurrent VTE for patients with an initial unprovoked event, and the pooled results of the 2 trials showed a decrease in recurrent VTE, as well as major vascular events, without an increased risk for clinically relevant bleeding. 309,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [315]
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,401
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Systematic Reviews in Health Care: Meta‐Analysis in Context
(2001) · doi:10.1002/9780470693926 · Cited by 1,693
Heit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis
Kahn, S. R., Shrier, I., Julian, J. A., Ducruet, T., Arsenault, L., Miron, M.-J., Roussin, A., Desmarais, S., Joyal, F., Kassis, J., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00004 · Cited by 854
Linkins, L.-A., Choi, P. T., & Douketis, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00007 · Cited by 764
Cited by
Items 501–600 of 600
Andrés Valenzuela, S., & Aizman, A. (2015) · Medwave · doi:10.5867/medwave.2015.03.6118
Duration of anticoagulation: the decision-making process
Thompson, R., & Thachil, J. V. (2015) · British Journal of Hospital Medicine · doi:10.12968/hmed.2015.76.10.c156
Platelets, Endothelium, and Inflammation
Ajzenberg, N., & Huisse, M. (2016) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_99-2
Will They Have an Impact? A Closer Look at Recent Nt th T i l Noteworthy Trials
Ellinger, L. K. (2013)
Ward, M., & Ranger, N. S. (2015)
Aktuelle Therapie und Sekundärprävention der Lungenembolie
Lankeit, M., & Konstantinides, S. (2014) · Gefässchirurgie · doi:10.1007/s00772-013-1286-6
Diener, H. (2013) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-013-0052-3
Radbel, J. M., Jobanputra, A. M., Singh, J. A., Jagpal, S. K., & Hussain, S. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1821rr
Antikoagulation nach tiefer Venenthrombose
Geier, B., Böhner, H., Balzer, K., Aleksic, M., Nowak, T., Klemp, U., Pillny, M., Kröger, K., & Pourhassan, S. (2013) · Gefässchirurgie · doi:10.1007/s00772-013-1129-5
Reicht für die Langzeitprophylaxe ASS allein? Sekundärprävention nach Thromboembolie
Radke, P. W. (2012) · CardioVasc · doi:10.1007/s15027-012-0335-5
Pulmonary embolism: clinical guidelines of European Society of Cardiology (2014)*
Article, E. (2015) · PULMONOLOGIYA · doi:10.18093/0869-0189-2015-25-6-649-684
Aspirin to Prevent Recurrent Venous Thromboembolism, Revisited
Brett, A. S. (2012) · Journal watch · doi:10.1056/jw201211040000001
Low-Dose Aspirin in the Cardiovascular System
Casado-Arroyo, R., Lanas, Á., & Brugada, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-33889-7_9
Böhner, H. (2016) · Gefässchirurgie · doi:10.1007/s00772-016-0214-y
Neue Möglichkeiten der oralen Langzeitantikoagulation
Regli, C., & Heizmann, M. (2016) · CardioVasc · doi:10.1007/s15027-016-1029-1
Jiménez-Guiu, X., Romera-Villegas, A., Mestre, F. J. M., Mestre, A. R., & Vila-Coll, R. (2016) · Angiología · doi:10.1016/j.angio.2016.11.001
Pulmoner Embolinin Güncel Tedavisi
Tekin, A. (2016) · Arşiv Kaynak Tarama Dergisi · doi:10.17827/aktd.248425
Preclinical evaluation of the antithrombotic potential of the most commonly prescribed antiplatelets
Ni, R. (2017) · MacSphere (McMaster University) · doi:10.71548/22191
ディベート1 : 静脈血栓塞栓症予防 : アスピリンは是か非か あくまでピンチヒッターでしかないアスピリン
悟, 藤. (2015) · 心臓 · doi:10.11281/shinzo.47.882
Ondrakova, M., Motovska, Z. J., Waldauf, P., Knot, J., Havlůj, L., Bittner, L., Bartoška, R., Gürlich, R., Krbec, M., Džupa, V., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177519
Dürschmied, D., Heinz, J., Siepe, M., & Bode, C. (2015)
Does aspirin have a role in preventing unprovoked recurrent thromboembolism?
Yenny, Y. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.18051/univmed.2013.v32.1-2
Palareti, G. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1366851
Le sulodexide, une option pour prévenir la récurrence de thrombose veineuse profonde
Allard, L., Laprise-Lachance, M., Roy, M., & Sylvain, L. T. (2017) · Pharmactuel
Long-term strategies in patients with unprovoked venous thromboembolism
Prandoni, P. (2017) · Phlebologie · doi:10.12687/phleb2372-5-2017
Karetová, D., & Bultas, J. (2017) · Klinická farmakologie a farmacie · doi:10.36290/far.2017.014
Inflammatory Bowel Diseases and Thrombosis. An Update. Review Article.
Fornaro, R., Caristo, G., Stratta, E., Valentina, V., Caratto, M., Caratto, E., Salerno, A., Giovinazzo, D., Sticchi, C., Marco, C., et al. (2017) · CINECA IRIS Institutial Research Information System (University of Genoa)
Prevention of Venous Thromboembolism
Sadaghianloo, N., & Dardik, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-65226-9_20
Lurie, F., Abbas, J. T., & Fish, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-65226-9_3
Thrombose, Lungenembolie und Antikoagulation: Wie und wie lange antikoagulieren?
Geisler, T., & Stimpfle, F. (2018) · Der Klinikarzt · doi:10.1055/a-0575-1650
y, P. A., Bayés‐Genís, A., de Isla, L. P., Sanchís, J. M., & Heras, M. (2016)
Anticoagulation in Venous Thromboembolism
Barnes, G. D., & Renner, E. T. (2018) · Springer eBooks · doi:10.1007/978-3-319-73709-6_14
Closing Patent Foramen Ovale (PFO) for Cryptogenic Stroke - Deeper Thoughts
Wong, C. K. (2018) · Cardiovascular Pharmacology Open Access · doi:10.4172/2329-6607.1000e139
EXTENDED ANTICOAGULANT THERAPYIN PATIENTS, WHO SURVIVED PULMONARY EMBOLISM
Vorobieva, N. M., & Панченко, Е. П. (2018) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2018-2-36-45
Cellular and Plasma Protein Crosstalk in Arterial and Venous Thrombosis
Aleman, M. M. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/4gmt-za98
Prevention of recurrent deep-vein thrombosis
Nicolaides, A. K. D. (2019) · Vascular Investigation and Therapy · doi:10.4103/vit.vit_8_19
Study of central venous catheter associated thrombosis in critically ill patients
Momtaz, O. M., mawla, T. A. E., kayal, E. E., & Amin, A. (2019) · Fayoum University Medical Journal/Fayoum University Medical Journal · doi:10.21608/fumj.2019.60338
Routine Anticoagulation for the Provoked and Unprovoked VTE
Bosch, M. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-25782-8_2
Triggers and risk factors of first and recurrent venous thromboembolism
Bjøri, E. (2020) · NORA - Norwegian Open Research Archives
Die neue Karriere von ASS in der Thromboembolie-Langzeitprophylaxe: Erst WARFASA, nun ASPIRE
Einecke, D. (2012) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-012-1422-3
Vilalta, N. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Jung, N., Mayet, W.-J., Mertens, P. R., Meyer, J., Müller, O.-A., Pfeifer, M. A., Schellinger, P. D., Weiss, N., & Wendtner, C. (2020) · Elsevier eBooks · doi:10.1016/b978-3-437-06282-7.50012-7
Extended therapy and secondary prevention of venous thromboembolic complications
Petrikov, A. S., & Игоревич, П. И. (2020) · I P Pavlov Russian Medical Biological Herald · doi:10.23888/pavlovj2020284548-566
Eapen, B. C., Hou, J. Y., & Pai, A. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-54947-9.00128-0
Razavipour, M., Ghaffari, S., Mohebi, M., & Amjadi, S. (2021) · Journal of Research in Orthopedic Science · doi:10.32598/jrosj.8.1.703.2
ANTITHROMBOTIC EFFECTS OF SULODEXIDE: A REVIEW ARTICLE
Frati-Munari, A. C., Lecuona-Huet, N. E., & Majluf‐Cruz, A. (2021) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/8746403
Role of Follow-Up Duplex Ultrasound Post-Deep Vein Thrombosis
Broering, M. J., & Muck, P. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-49616-6_67-1
Anticoagulant treatment after a bleeding event: between Scila and Caribda
Bucureşti, U. D. M. Ş. F. „. D., Diaconu, C. C., Hostiuc, M., Bucureşti, U. D. M. Ş. F. „. D., Ilie, M., Bucureşti, U. D. M. Ş. F. „. D., Bălăceanu, A. L., & Bucureşti, U. D. M. Ş. F. „. D. (2015) · Romanian Medical Journal · doi:10.37897/rmj.2015.3.14
Oa, T., & Олеговна, В. О. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-12-8-16
Bauersachs, R. M., & Krabbe, B. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_208-1
Pulmonary Embolism and Deep Vein Thrombosis
Hanna, E. B. (2022) · Wiley eBooks · doi:10.1002/9781119832737.ch21
Difficult Choice: When to Prolong Anticoagulation Therapy in Patients with Venous Thromboembolism?
Хрыщанович, В. Я., & Скобелева, Н. Я. (2021) · Кардиология в Беларуси · doi:10.34883/pi.2021.13.5.016
Clinical Applications of Aspirin
Schrör, K. (2016) · Wiley eBooks · doi:10.1002/9783527685059.ch4
Platelets, Endothelium, and Inflammation
Ajzenberg, N., & Huisse, M. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_99
(2016) · VASA · doi:10.1024/0301-1526/a000487
(2013) · British journal of surgery · doi:10.1002/bjs.9083
Platelet, Endothelium, and Inflammation
Ajzenberg, N., & Huisse, M. (2013) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_99-1
Becattini, C., Giustozzi, M., & Agnelli, G. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_162-1
The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism
Prandoni, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/13780_2016_29
Becattini, C., Giustozzi, M., & Agnelli, G. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_162
Aspirin for venous thromboembolism
Stein, P. D. (2016) · Wiley eBooks · doi:10.1002/9781119039112.ch108
4 Clinical applications of aspirin
Schrör, K. (2022) · De Gruyter eBooks · doi:10.1515/9783110746419-004
Predicting Thromboembolism in Hospitalized Patients with Ventricular Thrombus
Yang, Q., Quan, X., Lang, X., & Liang, Y. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2312390
Traitement anticoagulant de la maladie thromboembolique veineuse à la phase chronique
Élias, A., & Daoud-Elias, M. (2023) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2023.04.008
Flowreg: Latent Space Regularization Using Normalizing Flow For Limited Samples Learning
Wang, C., Gao, J., Yang, H., & Wang, H. (2023) · IEEE International Conference on Acoustics Speech and Signal Processing · doi:10.1109/icassp49357.2023.10097230
依力亚尔, 吐. (2023) · Pharmacy Information · doi:10.12677/pi.2023.125053
Subclass Feature Evaluation of Latent Diffusion Model
Foo, C. B., & Christopher, L. (2023) · IEEE Applied Imagery Pattern Recognition Workshop · doi:10.1109/aipr60534.2023.10440695
Aspirine et prévention de la récidive de la maladie veineuse thromboembolique
Salah, R. B., Derbel, A., Chabchoub, I., Frikha, F., Marzouk, S., & Bahloul, Z. (2024) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2024.101761
Predicting Fear of Breast Cancer Recurrence from Healthcare Reimbursement Data using Deep Learning
Koume, M., Seguin, L., Bouhnik, A., & Ureña, R. (2024) · Proceedings - IEEE Symposium on Computer-Based Medical Systems · doi:10.1109/cbms61543.2024.00018
Old Drugs: Confronting Recent Advancements and Challenges
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-6198-0
Trombolismo venoso: Los anticoagulantes orales de acción directa
Altman, R., & Luciardi, H. L. (2021) · Revista de la Federación Argentina de Cardiología · doi:10.63600/ckd3cz60
Khokhlov, I., Bolodurina, I. P., & Kolesnik, S. (2025) · International Russian Automation Conference (RusAutoCon) · doi:10.1109/rusautocon65989.2025.11177361
Platelets in Venous Thromboembolism
Riedl, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-96352-0_13
Liuzzo, G., & Patrono, C. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf967
Einfluss tumoröser Mikropartikel auf die Entstehung tiefer Venenthrombosen im murinen Stenosemodell
Schubert, I. (2013) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16013
Duration of Anticoagulant Therapy for Unprovoked Venous Thromboembolism
Khan, F. (2022) · uO Research (University of Ottawa) · doi:10.20381/ruor-28376
Orsi, L. D. A. F. (2020) · Leiden Repository (Leiden University)
Antiplatelet Therapy for Venous Thromboembolism
Poénou, G., & Heestermans, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-96360-5_13
ПРОДЛЕННАЯ АНТИКОАГУЛЯНТНАЯ ТЕРАПИЯ У ПАЦИЕНТОВ, ПЕРЕЖИВШИХ ТРОМБОЭМБОЛИЮ ЛЕГОЧНОЙ АРТЕРИИ
Михайловна, В. Н., & Павловна, П. Е. (n.d.) · CyberLeninK (CyberLeninka)
One-Year Performance of Long-Term Catheters in Hemodialysis Patients
Maghsoudlou, S., Amirkhanlou, S., Roshandel, G., & Kharazm, P. (2024) · “Polytechnic Bulletin” Series “Intellect Innovations Investments” · doi:10.61882/goums.26.2.22
Involvement of platelets in inflammation and cancer
Mezouar, S. (2015) · theses.fr (ABES) · doi:10.70675/3209f579z7718z497fzbe5dzd52f700a4270
Microparticles in colorectal and pancreatic cancers
Mège, D. (2016) · theses.fr (ABES) · doi:10.70675/53ccc88ez4c57z4521zabb5z8a40f9335ca7
Post-discharge Pulmonary Embolism Clinic
Troha, D. R., Zahid, I., Rosovsky, R. P., & HOOKS, B. J. (2026) · Springer eBooks · doi:10.1007/978-3-030-70904-4_36-1
mVI: High-Resolution Roadside Vehicle Imaging by MMWAVE
Xu, W., Yang, Y., Chen, Q., Han, M., Cao, Y., Guoming, Z., & Hu, P. (2026) · IEEE International Conference on Acoustics Speech and Signal Processing · doi:10.1109/icassp55912.2026.11461020
Mahmoud, A. A., & Kouides, P. A. (2026) · Springer eBooks · doi:10.1007/978-3-032-13858-3_46
Blanchard, M., Ducottet, C., Muselet, D., & Delézay, O. (2026) · IEEE Winter Conference on Applications of Computer Vision · doi:10.1109/wacv61042.2026.00523
G protein-coupled receptor-mediated platelet thrombus formation
Zhao, X., & Ma, P. (2026) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000931
Park, Y. U., Jun, J., Sakong, S., Lee, M., & Seo, Y. W. (2026) · Clinics in Orthopedic Surgery · doi:10.4055/cios25389
Antiplatelet therapy in pulmonary embolism: Mechanisms and evidence
Kalamara, T.-V., Dodos, K., & Georgakopoulou, V. (2026) · World Journal of Translational Medicine · doi:10.5528/wjtm.121879
Eapen, B. C., Saber, M. H., & Oshiro, R. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-23516-0.00122-7
Pulmonary Embolism and Deep Vein Thrombosis
Hanna, E. B. (2026) · Wiley eBooks · doi:10.1002/9781394406999.ch21
Contemporary anticoagulation management in pulmonary embolism
Hammerschlag, G., Yo, S., Lawton, E., & Dunn, A. (2026) · Thrombosis Research · doi:10.1016/j.thromres.2026.109854
COVID-19 and thrombotic risk in patients with active cancer: a matched cohort study
Doyen, J., Lacour, A., Schiappa, R., Seutin, E., Garrido, A., Loscos, T. P., & Doyen, D. (2026) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkag110
Strelau, M., Gal, G. L., McCurdy, A. B. R., Shivakumar, S., Wootten, J. C., Abouzeenni, M., Phua, C. W. W., Lam, S., Lazo‐Langner, A., Abouzeenni, M. Y., et al. (2026) · Current Oncology · doi:10.3390/curroncol33100633
Meng, S., Yu, S., Zhu, X., Zhou, S., Zhu, S., Yu, Y., Xie, Y., Huang, Z., Xiang, M., & Ma, H. (2026) · Scientific Reports · doi:10.1038/s41598-026-77293-z
Fatemi, N., Karimpour, M., Bahrami, H., Zali, M. R., Chaleshi, V., Riccio, A., Nazemalhosseini-Mojarad, E., & Totonchi, M. (2024) · doi:10.3389/fphar.2023.1329244.s001
Brown, L. C., McCormack, M. J., Ruggeri, A., Norek, S., Ahmed, F., Symanowski, J. T., Grigg, C. M., Zhu, J., & Burgess, E. F. (2026) · Future Oncology · doi:10.1080/14796694.2026.2759456
Metadata
- Authors
- Brighton, T. A., Eikelboom, J. W., Mann, K., Mister, R., Gallus, A., Ockelford, P., Gibbs, H., Hague, W., Xavier, D., Diaz, R., Kirby, A., & Simes, J.
- Affiliations
- Prince of Wales Hospital (AU)
- Population Health Research Institute (CA)
- The University of Sydney (AU)
- South Australia Pathology (AU)
- Auckland City Hospital (NZ)
- The Alfred Hospital (AU)
- St.John's Medical College Hospital (IN)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-11-22
- Volume
- 367
- Issue
- 21
- Pages
- 1979-1987
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2162531249
- Cited by
- 563
- References
- 24
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 39 · 2023: 24 · 2022: 25 · 2021: 33 · 2020: 37 · 2019: 30 · 2018: 35 · 2017: 49 · 2016: 51 · 2015: 56 · 2014: 60 · 2013: 69 · 2012: 8
- FWCI
- 41.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- low-dose aspirin, venous thromboembolism, recurrence prevention, unprovoked venous thromboembolism, anticoagulation discontinuation, secondary prevention, cardiovascular events, bleeding risk, major vascular events, net clinical benefit, thromboprophylaxis, stroke, myocardial infarction
- MeSH terms
- Aspirin, Double-Blind Method, Female, Follow-Up Studies, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Risk, Incidence, Venous Thromboembolism, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.